NO954739L - Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene - Google Patents

Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene

Info

Publication number
NO954739L
NO954739L NO954739A NO954739A NO954739L NO 954739 L NO954739 L NO 954739L NO 954739 A NO954739 A NO 954739A NO 954739 A NO954739 A NO 954739A NO 954739 L NO954739 L NO 954739L
Authority
NO
Norway
Prior art keywords
diagnostic
drug
compounds
processes
preparation
Prior art date
Application number
NO954739A
Other languages
English (en)
Other versions
NO954739D0 (no
Inventor
Jan-Robert Schwark
Heinz-Werner Kleemann
Hans-Jochen Lang
Andreas Weichert
Wolfgang Scholz
Udo Albus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO954739D0 publication Critical patent/NO954739D0/no
Publication of NO954739L publication Critical patent/NO954739L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Det er beskrevet benzoylguanidiner med formel (I) hvori R(l) betyr R(6)-CO eller R(7)R(8)N-CO, med R(2) definert som R(l), eller l betydningen H, OH, Hal, CN, N02, (pernuor)alk(en)yl, -(CH)2R(15), eller R(2) betyr (Cj-CgJ-heteroaryl, eller R(2) betyr SR(18), -OR(18). -NR(18)R(19). -CR(18)R(19)R(20); eller (R2) betyr R(21-S0n, eller R(22)R(23)N-S02-, eller R(2) betyr R(33)X-, hvorved X betyr oksygen, S, NR(34), (D-O)A-, NR(34)OMN(I<)R(35)-, eller R(2) betyr -SR(40), -OR(40), NHR(40), -NR(40)R(41), -CHR(40)R(42), -CR(42)R(43)OH, -C=CR(45), -CR(46)-CR(45) eller-[CR(47)R(48)]U-CO-[CR(49)R(50)]V-R(44); eller i R(2) betyr R(55)-HH-S02-, R(3), R(4) og R(5) er uavhengig av hverandre definert som R(l) eller R(2), ! hvorved imidlertid minst en av substltuentene R(2), R(3), R(4) og R(5) må være Ilk OH; samt deres farmasøytisk godtagbare salter.
NO954739A 1994-11-24 1995-11-23 Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene NO954739L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4441880A DE4441880A1 (de) 1994-11-24 1994-11-24 Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (2)

Publication Number Publication Date
NO954739D0 NO954739D0 (no) 1995-11-23
NO954739L true NO954739L (no) 1996-05-28

Family

ID=6534070

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954739A NO954739L (no) 1994-11-24 1995-11-23 Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene

Country Status (18)

Country Link
EP (1) EP0713864A1 (no)
JP (1) JPH08225514A (no)
KR (1) KR960017628A (no)
CN (1) CN1132745A (no)
AU (1) AU3900895A (no)
BR (1) BR9505295A (no)
CA (1) CA2163598A1 (no)
CZ (1) CZ308495A3 (no)
DE (1) DE4441880A1 (no)
FI (1) FI955614A (no)
HR (1) HRP950570A2 (no)
HU (1) HUT73789A (no)
IL (1) IL116096A0 (no)
NO (1) NO954739L (no)
NZ (1) NZ280517A (no)
PL (1) PL311467A1 (no)
SI (1) SI9500362A (no)
ZA (1) ZA959972B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0765867A1 (de) * 1995-09-27 1997-04-02 Hoechst Aktiengesellschaft Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament
DE19540995A1 (de) * 1995-11-03 1997-05-07 Hoechst Ag Substituierte Sulfonimidamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19542306A1 (de) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE19738604A1 (de) * 1997-09-04 1999-03-11 Hoechst Marion Roussel De Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verminderung der Giftigkeit cardiotoxischer Stoffe

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0556673B1 (de) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
CZ284456B6 (cs) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje
ATE157351T1 (de) * 1993-02-20 1997-09-15 Hoechst Ag Substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament, als inhibitoren des zellulären na+/h+-austauschs oder als diagnostikum sowie sie enthaltendes medikament
DE4318756A1 (de) * 1993-06-05 1994-12-08 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
FI955614A0 (fi) 1995-11-22
DE4441880A1 (de) 1996-05-30
HUT73789A (en) 1996-09-30
CZ308495A3 (en) 1996-06-12
AU3900895A (en) 1996-05-30
CA2163598A1 (en) 1996-05-25
HU9503345D0 (en) 1996-01-29
ZA959972B (en) 1996-06-04
FI955614A (fi) 1996-05-25
SI9500362A (en) 1996-06-30
BR9505295A (pt) 1997-10-21
KR960017628A (ko) 1996-06-17
HRP950570A2 (en) 1997-08-31
EP0713864A1 (de) 1996-05-29
NZ280517A (en) 1996-09-25
PL311467A1 (en) 1996-05-27
CN1132745A (zh) 1996-10-09
NO954739D0 (no) 1995-11-23
IL116096A0 (en) 1996-01-31
JPH08225514A (ja) 1996-09-03

Similar Documents

Publication Publication Date Title
de Miranda et al. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS‐related complex
CA2144962A1 (en) 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers
PT891331E (pt) Derivados do acido n-(2-oxoacetil ou sulfonil)-pirrolidino/piperidina-2-carboxilico com actividade melhorada de resistencia a multifarmacos
HUP9800460A2 (hu) 5-Amino-levulinsav-észterek fotokemoterápiai fotoszenzibilizáló szerként történő alkalmazásra
ATE224888T1 (de) Pyridylalken- und pyridylalkin-säureamide als cytostatika und immunosuppressive arzneimittel
HUP0102793A2 (hu) Agydaganat kezelésére szolgáló kinazolinok és ezeket tartalmazó gyógyszerkészítmények
CA2186380A1 (en) Novel carbamates and ureas as modifiers of multi-drug resistance
MX9707453A (es) Derivados de quinazolina.
HUP0104662A2 (hu) Kombinált 5HT1A, 5HT1B és 5HT1D receptor antagonista aktivitással rendelkező kinolinszármazékok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
DE69841367D1 (de) Peptidderivate oder deren pharmazeutisch annehmbare salze, verfahren zu deren herstellung, verwendung dieser derivate und arzneimittel
TR200000223T2 (tr) XA faktörünü engelleyen heterosiklik türevler
BR9714677A (pt) &#34;enantiÈmeros 3-piridila e seu uso como analgésicos&#34;
NO954739L (no) Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende disse forbindelsene
TR199900503T2 (xx) 3-�kameli pirido $4&#39;,3&#39;:4,5]thieno $2,3-D] pirimidin-t�revleri, elde edili�leri ve kullan�mlar�.
HUP0100276A2 (hu) Szubsztituált krománszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ES2128043T3 (es) Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
HUP0103303A2 (hu) Imidazolvegyületek, eljárás előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
BG50159A3 (en) Method for preparing derivatives of piranobenzadiasole
EP0222283A3 (en) Amino-acid derivatives
PT986386E (pt) Uso de derivados heterociclicos aromaticos com azoto no tratamento topico de doencas dos tecidos epiteliais
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
Saishu et al. Resistance of thermophilic ATPase (TF1) to specific F1-atpase inhibitors including local anesthetics
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
NO960812L (no) Alkoksysubstituerte ptoren